"For many scientists, the idea of translating innovative lab-based technology into applications that will help society is very exciting. ICFO's innovation-friendly and supportive environment is making it possible for HemoPhotonics to pinpoint the practical solutions which will maximize the utility of our non-invasive technology for researchers and doctors working with hemodynamic parameters"

— Dr. Udo Weigel

HemoPhotonics S.L. spun out of ICFO in April 2013 after two years of incubation in ICFO's KTT Launchpad under the supervision of ICFO Group Leader Prof. Turgut Durduran. The new high tech company is a result of Prof. Durduran’s extensive know-how in medical optics and optical monitors. HemoPhotonics set up house in ICFO's incubator and is devoted to translating light-based technologies into compact and customized systems for non-invasive measurement of cerebral hemodynamics for clinical and scientific research applications.


The ICFOnian behind this new venture is Udo Weigel , who is CEO and co-founder of the new company. Udo obtained his PhD at Ruprecht-Karls University Heidelberg, Germany and has extensive experience in translational research. After working in both a university and industrial setting, he joined Prof. Turgut Durduran’s group at ICFO as a postdoctoral researcher in 2009. During the last two years of his postdoc, he led the pre-commercial prototype development project, partially financed under the Prova’t funding scheme, which led to the formation of the company.

signa5.jpg
Udo with Prof Turgut Durduran and Prof. Lluis Torner, in the official signature of the tech transfer agreement
prototype.jpg
HemoPhotonics' Optical Monitor prototype
Turgut.jpg
HemoPhotonics' Optical Monitor at the Intensive Care Unit of Hospital Clinic in Barcelona
signa1.jpg
Udo with ICFO's director, Prof Lluís Torner, in the official signature of the tech transfer agreement